U.S. markets closed

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.15-0.40 (-2.16%)
At close: 4:00PM EST

18.15 0.00 (0.00%)
After hours: 4:42PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/29/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
807.25M731.31M997.72M359.78M418.43M405.34M
Enterprise Value 3
829.02M773.40M1.00B372.86M431.85M425.97M
Trailing P/E
17.5116.6547.5318.6717.1415.82
Forward P/E 1
15.2415.43N/AN/A29.5918.98
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
3.193.044.901.832.092.00
Price/Book (mrq)
3.263.134.881.822.192.15
Enterprise Value/Revenue 3
3.2712.0611.826.519.118.38
Enterprise Value/EBITDA 6
10.9861.4925.6723.1255.8545.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3100.32%
S&P500 52-Week Change 316.56%
52 Week High 326.58
52 Week Low 35.51
50-Day Moving Average 318.14
200-Day Moving Average 318.52

Share Statistics

Avg Vol (3 month) 3574.03k
Avg Vol (10 day) 3465.99k
Shares Outstanding 542.86M
Float 37.27M
% Held by Insiders 11.38%
% Held by Institutions 194.13%
Shares Short (Nov 12, 2020) 43.44M
Short Ratio (Nov 12, 2020) 46.15
Short % of Float (Nov 12, 2020) 410.73%
Short % of Shares Outstanding (Nov 12, 2020) 47.98%
Shares Short (prior month Oct 14, 2020) 43.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 13, 2019
Ex-Dividend Date 4Jan 31, 2019
Last Split Factor 23:2
Last Split Date 3May 13, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 18.21%
Operating Margin (ttm)24.32%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)21.77%

Income Statement

Revenue (ttm)253.67M
Revenue Per Share (ttm)5.92
Quarterly Revenue Growth (yoy)26.20%
Gross Profit (ttm)156.25M
EBITDA 74.18M
Net Income Avi to Common (ttm)46.19M
Diluted EPS (ttm)1.07
Quarterly Earnings Growth (yoy)58.30%

Balance Sheet

Total Cash (mrq)63.45M
Total Cash Per Share (mrq)1.48
Total Debt (mrq)106.24M
Total Debt/Equity (mrq)45.53
Current Ratio (mrq)N/A
Book Value Per Share (mrq)5.45

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A